{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T15:06:17Z","timestamp":1784819177888,"version":"3.55.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003810","name":"Clinical Hospital of Porto Alegre (HCPA), Rio Grande do Sul, Brazil","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003810","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Brazilian National Institute of Science and Technology on Neuroimmunomodulation","award":["465489\/2014-1"],"award-info":[{"award-number":["465489\/2014-1"]}]},{"DOI":"10.13039\/501100003593","name":"National Council of Technological and Scientific Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordination for the Improvement of Higher Education Personnel","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"S\u00e3o Paulo Research Foundation","doi-asserted-by":"publisher","award":["2012\/50880-4"],"award-info":[{"award-number":["2012\/50880-4"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"S\u00e3o Paulo Research Foundation","doi-asserted-by":"publisher","award":["2015\/14343-2"],"award-info":[{"award-number":["2015\/14343-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003810","name":"Clinical Hospital of Porto Alegre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003810","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.neuropharm.2019.107930","type":"journal-article","created":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T11:26:26Z","timestamp":1577964386000},"page":"107930","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Effects of single-dose antipurinergic therapy on behavioral and molecular alterations in the valproic acid-induced animal model of autism"],"prefix":"10.1016","volume":"167","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1257-586X","authenticated-orcid":false,"given":"Mauro Mozael","family":"Hirsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iohanna","family":"Deckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00falio","family":"Santos-Terra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela Zanotto","family":"Staevie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mellanie","family":"Fontes-Dutra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Carello-Collar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00edlia","family":"K\u00f6rbes-Rockenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Brum Schwingel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme","family":"Bauer-Negrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna","family":"Rabelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carolina Bittencourt","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Corr\u00eaa-Velloso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahaira","family":"Naaldijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Regina Geciauskas","family":"Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victorio","family":"Bambini-Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8838-1300","authenticated-orcid":false,"given":"Carmem","family":"Gottfried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2019.107930_bib1","series-title":"(DSM-5), Diagnostic and Statistical Manual of Mental Disorders fourth ed","article-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.neuropharm.2019.107930_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6706a1","article-title":"Prevalence of autism spectrum disorder among children aged 8 Years - autism and developmental disabilities monitoring network, 11 sites, United States, 2014","volume":"67","author":"Baio","year":"2018","journal-title":"MMWR Surveillance Summ."},{"key":"10.1016\/j.neuropharm.2019.107930_bib3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.brainres.2011.06.015","article-title":"Animal model of autism induced by prenatal exposure to valproate: behavioral changes and liver parameters","volume":"1408","author":"Bambini-Junior","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2019.107930_bib4","first-page":"178","article-title":"Resveratrol prevents social deficts in animal model of autism induced by valproic acid","volume":"483","author":"Bambini-Junior","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2019.107930_bib5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3389\/fnbeh.2018.00230","article-title":"Increasing role of maternal immune activation in neurodevelopmental disorders","volume":"12","author":"Boulanger-Bertolus","year":"2018","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107930_bib6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bcp.2017.07.016","article-title":"The therapeutic potential of purinergic signalling","volume":"151","author":"Burnstock","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2019.107930_bib7","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1212\/WNL.58.3.428","article-title":"Minicolumnar pathology in autism","volume":"58","author":"Casanova","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2019.107930_bib8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.31887\/DCNS.2012.14.3\/pchaste","article-title":"Autism risk factors: genes, environment, and gene-environment interactions","volume":"14","author":"Chaste","year":"2012","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107930_bib9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/mp.2017.188","article-title":"Purinergic system in psychiatric diseases","volume":"23","author":"Cheffer","year":"2018","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2019.107930_bib10","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.2013.2270","article-title":"Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism","volume":"309","author":"Christensen","year":"2013","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.neuropharm.2019.107930_bib11","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s40489-015-0051-z","article-title":"Exploring the potential role of inflammation as an etiological process in ASD","volume":"2","author":"Elias","year":"2015","journal-title":"Rev. J. Autism Dev. Disord."},{"key":"10.1016\/j.neuropharm.2019.107930_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.mam.2017.01.002","article-title":"Extracellular ATP and adenosine: the Yin and Yang in immune responses?","volume":"55","author":"Faas","year":"2017","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.neuropharm.2019.107930_bib13","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/ana.10596","article-title":"Mitochondrial dysfunction in autistic patients with 15q inverted duplication","volume":"53","author":"Filipek","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2019.107930_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbr.2019.01.034","article-title":"Abnormal empathy-like pro-social behaviour in the valproic acid model of autism spectrum disorder","volume":"364","author":"Fontes-Dutra","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2019.107930_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fnsyn.2018.00009","article-title":"Resveratrol prevents cellular and behavioral sensory alterations in the animal model of autism induced by valproic acid","volume":"10","author":"Fontes-Dutra","year":"2018","journal-title":"Front. Synaptic Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107930_bib16","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1478-811X-11-12","article-title":"Implications of purinergic receptor-mediated intracellular calcium transients in neural differentiation","volume":"11","author":"Glaser","year":"2013","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.neuropharm.2019.107930_bib17","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s11689-009-9023-x","article-title":"Common circuit defect of excitatory-inhibitory balance in mouse models of autism","volume":"1","author":"Gogolla","year":"2009","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.neuropharm.2019.107930_bib18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fpsyt.2015.00121","article-title":"The impact of neuroimmune alterations in autism spectrum disorder","volume":"6","author":"Gottfried","year":"2015","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.neuropharm.2019.107930_bib19","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1054-3589(08)60486-X","article-title":"Suramin: with special reference to onchocerciasis","volume":"15","author":"Hawking","year":"1978","journal-title":"Adv. Pharmacol. Chemother."},{"key":"10.1016\/j.neuropharm.2019.107930_bib20","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.fct.2018.02.061","article-title":"Behavioral alterations in autism model induced by valproic acid and translational analysis of circulating microRNA","volume":"115","author":"Hirsch","year":"2018","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.neuropharm.2019.107930_bib21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/s41398-018-0155-1","article-title":"Glutamate and GABA in autism spectrum disorder\u2014a translational magnetic resonance spectroscopy study in man and rodent models","volume":"8","author":"Horder","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2019.107930_bib22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.comppsych.2017.12.005","article-title":"Abnormal perceptual sensitivity in body-focused repetitive behaviors","volume":"82","author":"Houghton","year":"2018","journal-title":"Compr. Psychiatr."},{"key":"10.1016\/j.neuropharm.2019.107930_bib23","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2144\/000112401","article-title":"Isolation and solubilization of proteins after TRIzol extraction of RNA and DNA from patient material following prolonged storage","volume":"42","author":"Hummon","year":"2007","journal-title":"Biotechniques"},{"key":"10.1016\/j.neuropharm.2019.107930_bib24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/nan.12227","article-title":"Review: cortical construction in autism spectrum disorder: columns, connectivity and the subplate","volume":"42","author":"Hutsler","year":"2016","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.neuropharm.2019.107930_bib25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0306-4522(01)00556-5","article-title":"ATP stimulates peripheral axons in human, rat and mouse--differential involvement of A(2B) adenosine and P2X purinergic receptors","volume":"110","author":"Irnich","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2019.107930_bib26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.brainresbull.2016.03.013","article-title":"Memantine ameliorates autistic behavior, biochemistry & blood brain barrier impairments in rats","volume":"124","author":"Kumar","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2019.107930_bib27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainres.2015.10.052","article-title":"Minocycline ameliorates prenatal valproic acid induced autistic behaviour, biochemistry and blood brain barrier impairments in rats","volume":"1630","author":"Kumar","year":"2016","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2019.107930_bib28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.neuint.2015.10.007","article-title":"Benefits of agomelatine in behavioral, neurochemical and blood brain barrier alterations in prenatal valproic acid induced autism spectrum disorder","volume":"91","author":"Kumar","year":"2015","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2019.107930_bib29","article-title":"The amygdala excitatory\/inhibitory balance in a valproate-induced rat autism model","volume":"8","author":"Lin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2019.107930_bib30","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.neuropharm.2019.107930_bib31","doi-asserted-by":"crossref","first-page":"285","DOI":"10.5607\/en.2015.24.4.285","article-title":"Exploring the validity of valproic acid animal model of autism","volume":"24","author":"Mabunga","year":"2015","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.neuropharm.2019.107930_bib32","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/sj.npp.1301453","article-title":"Abnormal fear conditioning and amygdala processing in an animal model of autism","volume":"33","author":"Markram","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2019.107930_bib33","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0006-8993(01)03125-0","article-title":"Reduction by sevoflurane of adenosine 5\u2019-triphosphate-activated inward current of locus coeruleus neurons in pontine slices of rats","volume":"921","author":"Masaki","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2019.107930_bib34","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1089\/neu.2009.1237","article-title":"The whisker nuisance task identifies a late-onset, persistent sensory sensitivity in diffuse brain-injured rats","volume":"27","author":"McNamara","year":"2010","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.neuropharm.2019.107930_bib35","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1177\/1362361314527839","article-title":"Acute pain experience in individuals with autism spectrum disorders: a review","volume":"19","author":"Moore","year":"2015","journal-title":"Autism"},{"key":"10.1016\/j.neuropharm.2019.107930_bib36","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.brainres.2007.11.043","article-title":"Swim stress exaggerates the hyperactive mesocortical dopamine system in a rodent model of autism","volume":"1193","author":"Nakasato","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2019.107930_bib37","doi-asserted-by":"crossref","first-page":"e400","DOI":"10.1038\/tp.2014.33","article-title":"Reversal of autism-like behaviors and metabolism in adult mice with single-dose antipurinergic therapy","volume":"4","author":"Naviaux","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2019.107930_bib38","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/acn3.424","article-title":"Low-dose suramin in autism spectrum disorder: a small, phase I\/II, randomized clinical trial","volume":"4","author":"Naviaux","year":"2017","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.neuropharm.2019.107930_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057380","article-title":"Antipurinergic therapy corrects the autism-like features in the poly(IC) mouse model","volume":"8","author":"Naviaux","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2019.107930_bib40","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.neuropharm.2015.10.008","article-title":"Purinergic receptors in embryonic and adult neurogenesis","volume":"104","author":"Oliveira","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2019.107930_bib41","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/aur.1792","article-title":"Next generation sequencing mitochondrial DNA analysis in autism spectrum disorder","volume":"10","author":"Patowary","year":"2017","journal-title":"Autism Res."},{"key":"10.1016\/j.neuropharm.2019.107930_bib42","doi-asserted-by":"crossref","first-page":"34R","DOI":"10.1203\/PDR.0b013e318212b80f","article-title":"Modeling autistic features in animals","volume":"69","author":"Patterson","year":"2011","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.neuropharm.2019.107930_bib43","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0304-3940(02)01423-4","article-title":"Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data","volume":"339","author":"Ramakers","year":"2003","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2019.107930_bib44","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cub.2015.11.019","article-title":"Reduced GABAergic action in the autistic brain","volume":"26","author":"Robertson","year":"2016","journal-title":"Curr. Biol."},{"key":"10.1016\/j.neuropharm.2019.107930_bib45","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/(SICI)1097-0231(19981015)12:19<1319::AID-RCM332>3.0.CO;2-J","article-title":"Investigation of suramin-albumin binding by electrospray mass spectrometry","volume":"12","author":"Roboz","year":"1998","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.neuropharm.2019.107930_bib46","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ntt.2013.01.004","article-title":"In utero exposure to valproic acid and autism - a current review of clinical and animal studies","volume":"36","author":"Roullet","year":"2013","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.neuropharm.2019.107930_bib47","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.npp.1300518","article-title":"Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism","volume":"30","author":"Schneider","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2019.107930_bib48","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.psyneuen.2008.02.011","article-title":"Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid","volume":"33","author":"Schneider","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2019.107930_bib49","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00213-007-0795-y","article-title":"Prenatal exposure to valproic acid disturbs the enkephalinergic system functioning, basal hedonic tone, and emotional responses in an animal model of autism","volume":"193","author":"Schneider","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2019.107930_bib50","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/CHI.0b013e318179964f","article-title":"Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample","volume":"47","author":"Simonoff","year":"2008","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"40","key":"10.1016\/j.neuropharm.2019.107930_bib51","doi-asserted-by":"crossref","first-page":"10695","DOI":"10.1523\/JNEUROSCI.2178-07.2007","article-title":"Maternal immune activation alters fetal brain development through interleukin-6","volume":"27","author":"Smith","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2019.107930_bib52","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bbr.2012.04.038","article-title":"Abnormal grooming activity in Dab1(scm) (scrambler) mutant mice","volume":"233","author":"Strazielle","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2019.107930_bib53","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.neures.2006.10.018","article-title":"Abnormality of circadian rhythm accompanied by an increase in frontal cortex serotonin in animal model of autism","volume":"57","author":"Tsujino","year":"2007","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2019.107930_bib54","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s12015-012-9372-9","article-title":"Extrinsic purinergic regulation of neural stem\/progenitor cells: implications for CNS development and repair","volume":"8","author":"Ulrich","year":"2012","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.neuropharm.2019.107930_bib55","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s10567-011-0097-0","article-title":"Anxiety disorders in children and adolescents with autistic spectrum disorders: a meta-analysis","volume":"14","author":"van Steensel","year":"2011","journal-title":"Clin. Child Fam. Psychol. Rev."},{"key":"10.1016\/j.neuropharm.2019.107930_bib56","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"Vandesompele","year":"2002","journal-title":"Genome Biol."},{"key":"10.1016\/j.neuropharm.2019.107930_bib57","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.bbadis.2012.01.011","article-title":"Brain IL-6 elevation causes neuronal circuitry imbalances and mediates autism-like behaviors","volume":"1822","author":"Wei","year":"2012","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.neuropharm.2019.107930_bib58","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1469-8749.2001.tb00188.x","article-title":"Fetal valproate syndrome and autism: additional evidence of an association","volume":"43","author":"Williams","year":"2001","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.neuropharm.2019.107930_bib59","doi-asserted-by":"crossref","first-page":"531518","DOI":"10.1155\/2015\/531518","article-title":"Inflammatory cytokines: potential biomarkers of immunologic dysfunction in autism spectrum disorders","volume":"2015","author":"Xu","year":"2015","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.neuropharm.2019.107930_bib60","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/sj.bjp.0706179","article-title":"Purinergic modulation of cardiovascular function in the rat locus coeruleus","volume":"145","author":"Yao","year":"2005","journal-title":"Br. J. Pharmacol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390819305015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390819305015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:00:06Z","timestamp":1758438006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390819305015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":60,"alternative-id":["S0028390819305015"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.107930","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of single-dose antipurinergic therapy on behavioral and molecular alterations in the valproic acid-induced animal model of autism","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2019.107930","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107930"}}